UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Verbesserte Selektivität und Aktivität der Deoxydehydratisierung durch ein gasdurchströmtes offenes Reaktionssetup

Chemie ingenieur technik, 2014-09, Vol.86 (9), p.1497-1498

2014

Volltextzugriff (PDF)

Verbesserte Selektivität und Aktivität der Deoxydehydratisierung durch ein gasdurchströmtes offenes Reaktionssetup

Chemie ingenieur technik, 2014-09, Vol.86 (9), p.1497-1498

2014

Volltextzugriff (PDF)

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

The Lancet (British edition), 2012-11, Vol.380 (9856), p.1829-1839

2012

Volltextzugriff (PDF)

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

Multiple sclerosis, 2022-07, Vol.28 (8), p.1277-1285

2022

Volltextzugriff (PDF)

Opioid Prescribing and Opioid Risk Mitigation Strategies in the Veterans Health Administration

Journal of general internal medicine : JGIM, 2020-12, Vol.35 (Suppl 3), p.927-934

2020

Volltextzugriff (PDF)

Risk-sensitive innovation: leveraging interactions between technologies to navigate technology risks

Science & public policy, 2024-07

2024

Volltextzugriff (PDF)

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Journal of neurology, neurosurgery and psychiatry, 2014-11, Vol.85 (11), p.1183-1189

2014

Volltextzugriff (PDF)

A Temporally Asymmetric Hebbian Rule Governing Plasticity in the Human Motor Cortex

Journal of neurophysiology, 2003-05, Vol.89 (5), p.2339-2345

2003

Volltextzugriff (PDF)

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Neurology, 2006-10, Vol.67 (7), p.1242-1249

2006

Volltextzugriff (PDF)

Postamputation limb pain in military personnel: separate but equal or separate and never equal?

Pain (Amsterdam), 2024-04, Vol.165 (4), p.723-724

2024

Volltextzugriff (PDF)

Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis

The New England journal of medicine, 2007-01, Vol.356 (4), p.371-378

2007

Volltextzugriff (PDF)

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Lancet neurology, 2009-11, Vol.8 (11), p.987-997

2009

Volltextzugriff (PDF)

Vitamin D as an early predictor of multiple sclerosis activity and progression

JAMA neurology, 2014-03, Vol.71 (3), p.306

2014

Volltextzugriff (PDF)

Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern

Frontiers in bioengineering and biotechnology, 2023-04, Vol.11, p.1124100-1124100

2023

Volltextzugriff (PDF)

A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care

BMC psychiatry, 2023-03, Vol.23 (1), p.177-10, Article 177

2023

Volltextzugriff (PDF)

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

Lancet neurology, 2009-12, Vol.8 (12), p.1111-1119

2009

Volltextzugriff (PDF)

The Use of Opioids in the Management of Chronic Pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline

Annals of internal medicine, 2023-03, Vol.176 (3), p.388-397

2023

Volltextzugriff (PDF)

The Use of Opioids in the Management of Chronic Pain

Annals of internal medicine, 2023-09, Vol.176 (9)

2023

Volltextzugriff (PDF)

Clinical Policy Recommendations from the VHA State-of-the-Art Conference on Non-Pharmacological Approaches to Chronic Musculoskeletal Pain

Journal of general internal medicine : JGIM, 2018-05, Vol.33 (Suppl 1), p.16-23

2018

Volltextzugriff (PDF)

Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises

Pain medicine (Malden, Mass.), 2020-07, Vol.21 (7), p.1331-1346

2020

Volltextzugriff (PDF)

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

JAMA neurology, 2015-12, Vol.72 (12), p.1458

2015

Volltextzugriff (PDF)

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Neurology, 2016-09, Vol.87 (10), p.978-987

2016

Volltextzugriff (PDF)

sequence of the Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus genome

Journal of general virology, 2001, Vol.82 (1), p.241-257

2001

Volltextzugriff (PDF)

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

Annals of neurology, 2011-12, Vol.70 (6), p.897-912

2011

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(101)
Deutsch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Verbesserte Selektivität und Aktivität der Deoxydehydratisierung durch ein gasdurchströmtes offenes Reaktionssetup

Verbesserte Selektivität und Aktivität der Deoxydehydratisierung durch ein gasdurchströmtes offenes Reaktionssetup

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

Opioid Prescribing and Opioid Risk Mitigation Strategies in the Veterans Health Administration

Risk-sensitive innovation: leveraging interactions between technologies to navigate technology risks

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

A Temporally Asymmetric Hebbian Rule Governing Plasticity in the Human Motor Cortex

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Postamputation limb pain in military personnel: separate but equal or separate and never equal?

Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Vitamin D as an early predictor of multiple sclerosis activity and progression

Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern

A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

The Use of Opioids in the Management of Chronic Pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline

The Use of Opioids in the Management of Chronic Pain

Clinical Policy Recommendations from the VHA State-of-the-Art Conference on Non-Pharmacological Approaches to Chronic Musculoskeletal Pain

Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

sequence of the Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus genome

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

Suchergebnisse filtern